LATISSE® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker, and darker. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
Take a moment to assess your lashes.
Perhaps you’ve noticed a change in your lashes over the years. Have they lost their fullness? Do they appear shorter? Or lighter in color? If so, it’s time to consider LATISSE® – the only FDA-approved product that grows lashes, increasing their overall prominence.
LATISSE® can grow thinning lashes.
In the US Phase III LATISSE® clinical trial, 91% of women participating (n=134) were 35 or older2, and results show that LATISSE® more than doubled lash fullness after 16 weeks of treatment for these patients.
Data on thinning lashes!
You may be surprised to know that published expert opinions have linked thinning and loss of eyelashes to aging. This finding led Allergan to analyze the photos of a subset of women with inadequate or not enough lashes pooled from three LATISSE® clinical trials. The results revealed that the older women had thinner, shorter, and lighter lashes at week 0, compared to the younger women in the trials. The demographic data suggests there may be a downward trend of eyelash fullness, length, and darkness as women with inadequate lashes age.
LATISSE® - Results after 16 week of treatments